AbbVie ABBV
NYSE ABBV
$276.48 +4.06 (+1.49%)
At close: Oct 9, 2026 · 4:00 PM EDT

AbbVie (ABBV) Non-Current Deferred Tax Liability (2012 - 2026)

Updated

AbbVie's Non-Current Deferred Tax Liability came in at $2.28 billion for Q2 2026, down 10.8% from $2.55 billion a year earlier and down 2.4% from the prior quarter.

Analysis

AbbVie (ABBV) Non-Current Deferred Tax Liability (2012 - 2026) Analysis & Trends

At the end of FY2025, AbbVie's Non-Current Deferred Tax Liability was $2.39 billion, down 7.4% from FY2024.

  • Non-Current Deferred Tax Liability carries a five-year compound annual growth rate of -8.1% (FY2020 to FY2025).
  • Going back by year, Non-Current Deferred Tax Liability was $2.58 billion in FY2024 (+32.1%), $1.95 billion in FY2023 (-10.9%), $2.19 billion in FY2022 (-27.2%) and $3.01 billion in FY2021 (-17.5%).
  • The Q2 2026 figure represents the lowest quarterly Non-Current Deferred Tax Liability since Q4 2023.
  • Year-over-year, Non-Current Deferred Tax Liability has declined for six consecutive quarters, with growth averaging 2.2% over the last eight quarters.
  • The fastest year-over-year change in Non-Current Deferred Tax Liability over five years came in Q3 2024 (growth of 34.5%), and the weakest in Q3 2022 (a decline of 45.3%).
  • Business Quant data shows ABBV's Non-Current Deferred Tax Liability at $2.33 billion (Q1 2026), $2.39 billion (Q4 2025) and $2.48 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,109.58 Bn 1,078.16 Bn 19.71 Bn
2 Johnson & Johnson 630.16 Bn 548.69 Bn 17.26 Bn
3 AbbVie 488.57 Bn 461.73 Bn 12.70 Bn
4 Merck 359.15 Bn 313.58 Bn 12.21 Bn
5 Novartis Ag 274.32 Bn 238.71 Bn 11.24 Bn
6 Astrazeneca 246.73 Bn 220.50 Bn 12.86 Bn
7 Amgen 224.28 Bn 179.68 Bn 7.24 Bn
8 Gilead Sciences 187.60 Bn 161.71 Bn 6.22 Bn
9 Pfizer 161.13 Bn 108.08 Bn 10.94 Bn
10 Vertex Pharmaceuticals 129.23 Bn 101.23 Bn 2.84 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.28 Bn
Mar 31, 2026 2.33 Bn
Dec 31, 2025 2.39 Bn
Sep 30, 2025 2.48 Bn
Jun 30, 2025 2.55 Bn
Mar 31, 2025 2.58 Bn
Dec 31, 2024 2.58 Bn
Sep 30, 2024 2.75 Bn
Jun 30, 2024 2.73 Bn
Mar 31, 2024 2.72 Bn
Dec 31, 2023 1.95 Bn
Sep 30, 2023 2.04 Bn
Jun 30, 2023 2.12 Bn
Mar 31, 2023 2.11 Bn
Dec 31, 2022 2.19 Bn
Sep 30, 2022 1.97 Bn
Jun 30, 2022 2.26 Bn
Mar 31, 2022 2.83 Bn
Dec 31, 2021 3.01 Bn
Sep 30, 2021 3.60 Bn
API Access

AbbVie Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=ABBV&period=max&api_key=YOUR_API_KEY